Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > USAMRIID ARE SUCCESSFULL / NEWS TO FOLLOW

<< Previous

Bullboard Posts

Next >>

Comment by Robr84obert5050on Jan 15, 2021 12:27pm

91 Views

Post# 32306640

RE:RE:RE:USAMRIID ARE SUCCESSFULL / NEWS TO FOLLOW

If your comments are just "profound thoughts based on what you see", you might want to put a disclaimer in there somewhere. No threats from me bud, just a friendly reminder as your posts don't come across as speculation AT ALL.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in